ABG
INSM icon

Ally Bridge Group’s Insmed INSM Stock Holding History

Ally Bridge Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,710
Closed -$4.8M – 28
2025
Q2 		$4.8M Sell
47,710
-37,400
-44% -$2.86M 4% 10
2025
Q1 		$6.49M Sell
85,110
-29,250
-26% -$2.24M 5.85% 7
2024
Q4 		$7.9M Sell
114,360
-36,473
-24% -$2.63M 6.77% 3
2024
Q3 		$11M Buy
150,833
+21,833
+17% +$1.61M 5.89% 1
2024
Q2 		$8.64M Sell
129,000
-121,000
-48% -$4.69M 5.15% 5
2024
Q1 		$6.78M Buy
+250,000
New +$7M 3.77% 13

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Ally Bridge Group's INSM Position: Q3 2025 in Review

Ally Bridge Group sold out of Insmed (INSM) in Q3 2025, closing a stake of 47,710 shares — an estimated $4.8M sold.

Ally Bridge Group first reported a position in INSM in Q1 2024 and held it in 6 quarters. The position peaked at $11M in Q3 2024. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Ally Bridge Group reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Ally Bridge Group sold 47,710 Insmed shares in Q3 2025, an estimated $4.8M.
  • Ally Bridge Group first reported a position in Insmed in Q1 2024 and held it in 6 quarters.
  • Ally Bridge Group's Insmed position peaked at $11M in Q3 2024.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Ally Bridge Group's 13F filing for Q3 2025, filed 14 Nov 2025.